Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
Boston Scientific Corp (BSX)
Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Here's Why You Should Retain Boston Scientific (BSX) Now Zacks - Mon Mar 20, 8:07AM CDT

Investors are optimistic about Boston Scientific (BSX), led by impressive value-added acquisitions.

BSX : 48.51 (-0.66%)
HAE : 79.16 (+1.25%)
KERN : 0.7900 (+1.28%)
TRSSF : 1.4300 (unch)
Abbott (ABT) Makes Progress in the TAVI Space With Navitor Zacks - Tue Mar 7, 8:45AM CST

Results from Abbott's (ABT) PORTICO study support Navitor's recent FDA approval to treat patients with severe aortic stenosis who are at high or extreme risk for open-heart surgery.

ABT : 97.77 (-0.10%)
BSX : 48.51 (-0.66%)
MDT : 80.45 (+1.06%)
EW : 81.23 (+0.19%)
Abbott's (ABT) MitraClip Device Shows Favorable Outcome Zacks - Tue Mar 7, 7:03AM CST

Abbott's (ABT) landmark COAPT trial demonstrated that MitraClip is safe and effective and can reduce the hospitalization rate.

ABT : 97.77 (-0.10%)
BSX : 48.51 (-0.66%)
MDT : 80.45 (+1.06%)
EW : 81.23 (+0.19%)
Boston Scientific (BSX) Down 1.7% Since Last Earnings Report: Can It Rebound? Zacks - Fri Mar 3, 10:30AM CST

Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BSX : 48.51 (-0.66%)
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises Zacks - Fri Feb 24, 7:50AM CST

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

JAZZ : 138.77 (+0.57%)
BSX : 48.51 (-0.66%)
BOSTON SCIENTIFIC INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX Business Wire - Fri Feb 17, 9:50PM CST

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Boston Scientific...

BSX : 48.51 (-0.66%)
Boston Scientific (BSX) Gains From New Buyouts, Cost Woes Stay Zacks - Thu Feb 16, 9:50AM CST

Boston Scientific's (BSX) EMEA business grows above market, supported by the company's ongoing investments in emerging markets.

BSX : 48.51 (-0.66%)
CAH : 71.78 (+0.90%)
MMSI : 71.54 (+0.66%)
AMN : 85.46 (+2.16%)
Boston Scientific to Participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference PR Newswire - Mon Feb 13, 8:30AM CST

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference on Wednesday,...

BSX : 48.51 (-0.66%)
BOSTON SCIENTIFIC INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX PR Newswire - Fri Feb 3, 9:50PM CST

/PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that...

BSX : 48.51 (-0.66%)
Boston Scientific Receives FDA Clearance for LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System PR Newswire - Fri Feb 3, 5:45AM CST

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite...

BSX : 48.51 (-0.66%)

Barchart Exclusives

Chart of the Day: PDF Solutions - Comprehensive Data Solutions Barchart - Tue Mar 21, 7:00AM CDT
The Chart of the Day belongs to the data solutions company PDF Solutions (PDFS) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot